SCHEMBL20250412

SCHEMBL20250412

c1ccc(-c2ccc3ccc4ccc(-c5ccc(-c6ccc(-c7ccc8ccc9cccc%10ccc7c8c9%10)c7ccccc67)cc5)nc4c3n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.43
CYP1A2 P05177 2/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 2/20 0.38
MEN1 O00255 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
THRB P10828 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
ENPP3 O14638 1/20 0.37
ENPP1 P22413 1/20 0.37
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17899307 0.97 PARP1 (0.46) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL20250350 0.96 PARP1 (0.43) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL20250418 0.96 PARP1 (0.44) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL20250339 0.93 PARP1 (0.44) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL19768388 0.92 PARP1 (0.42) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL21103895 0.92 PARP1 (0.42) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL20250476 0.91 PARP1 (0.39) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL21103667 0.91 PARP1 (0.41) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL19768562 0.90 PARP1 (0.47) PARP1CYP1A2ERBB2FYNMAOA
SCHEMBL19768445 0.89 CYP1A2 (0.39) PARP1CYP1A2ERBB2FYNMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10937984-B2 Organic compound and light emitting diode and organic light emitting diode display device using the same LG DISPLAY CO., LTD. (KR) 2021-03-02 US disclosed
US-20180166647-A1 ORGANIC COMPOUND AND LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166647-A1 ORGANIC COMPOUND AND LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10937984-B2 Organic compound and light emitting diode and organic light emitting diode display device using the same AOX1, ALDH1A2, OXER1 PARP1 3493/4885CYP1A2 60/4885ERBB2 1125/4885
US-20180166647-A1 ORGANIC COMPOUND AND LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE DISPLAY DEVICE USING THE SAME AOX1, ALDH1A2, OXER1 PARP1 3493/4885CYP1A2 60/4885ERBB2 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.